Apr 20, 2023 7:30 am EDT Kane Biotech Announces Distribution Agreement with ProgenaCare Global for its coactiv+™ Antimicrobial Wound Gel
Apr 18, 2023 7:30 am EDT Kane Biotech Announces Additional coactiv+™ Animal Health Licensing Agreement
Apr 13, 2023 4:30 pm EDT Kane Biotech to Release Fourth Quarter and Full Year 2022 Financial Results on April 20, 2023 – Conference Call to Follow
Mar 1, 2023 8:53 am EST Kane Biotech Announces Proposed Amendments to its Credit Facility and Changes to its Board of Directors
Feb 6, 2023 9:35 am EST Kane Biotech’s Coactiv+™ Technology Could Address a Pricey and Painful Problem: Lack of Healing in Chronic Wounds Due to Microbial Biofilm Formation
Jan 4, 2023 7:30 am EST Kane Biotech Announces First Distribution Agreement for its coactiv+™ Antimicrobial Hydrogel
